Systematic Reviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2280-2293
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2280
Table 1 Patient demographics
Ref.
Total number of patients
Mean age in years (range)
Gender ratio (M:F)
Burbidge et al[28], 201322069 (41-96)136:84
Li et al[29], 2020385--
Davies et al[30], 199710569 (33-92)68:37
Kim et al[31], 200949859.6 (27-89)332:166
Stell et al[32], 199610365 (33-91)68:35
Asencio et al[58], 19977165.8 (47-81)43:27
Fujimura et al[59], 200239(26-80)17:22
Leeman et al[60], 20177467.6 (29-84)54:20
Table 2 Tumour characteristics and computed tomography modality used
Ref.
Primary tumour location
Tumour histology
CT modality
Burbidge et al[28], 2013-Adenocarcinoma (220, 100%)Multidetector CT with gastric staging protocol
Li et al[29], 2020--Unenhanced, two-phase dynamic enhanced CT
Davies et al[30], 1997-Adenocarcinoma (105, 100%)Philips Tomoscan SR 7000 scanner (120 Kvp and 225-300 mAs), contrast enhanced spiral CT
Kim et al[31], 2009-Intestinal (162, 32.5%) 16-detector row (n = 427) or 64-detector row (n = 71) scanners
Diffuse (336, 67.5%)
Stell et al[32], 1996Proximal third (60, 58.3%)Adenocarcinoma (103, 100%)Contrast-enhanced CT using a GE model 9800 Hilight whole-body scanner (GEC, Milwaukee, Wisconsin, United States)
Body (24, 23.3%)
Antrum (10, 9.7%)
Body and antrum (6, 5.8%)
Fundus (2, 1.9%)
Linitis plastica (1, 1%)
Asencio et al[58], 1997Upper third (12, 17%)Adenocarcinoma (71, 100%)Dynamic contrast-enhanced CT
Middle third (21, 30%)
Lower third (19, 27%)
Fujimura et al[59], 2002Japanese classification of gastric carcinoma type 1 (1, 2.6%); type 2 (4, 10.3%); type 3 (14, 35.9%); type 4 (20, 51.3%)Differentiated (16, 41%)CT
Undifferentiated (23, 59%)
Leeman et al[60], 2017Proximal (7, 9.5%)Adenocarcinoma (74, 100%)Toshiba Aquilion 16 (16 slice), Siemens Somatom Sensation 16 (16 slice), Toshiba Aquilion Multi (4 slice)
Body (23, 31.1%)
Distal (10, 13.5%)
Linitis plastica (6, 8.1%)
Table 3 Statistical results of computed tomography and staging laparoscopy
Ref.Sensitivity
Specificity
Positive predictive value
Negative predictive value
CT
Staging laparoscopy
CT
Staging laparoscopy
CT
Staging laparoscopy
CT
Staging laparoscopy
Burbidge et al[28], 201325%-99%-83% -82%-
Li et al[29], 202087.5% -76.4%-31.8% -- -
Davies et al[30], 199771%-93%-67% -94%-
Kim et al[31], 200928.3%-98.9%-----
Asencio et al[58], 19970%88.9%-100%-100%-95.5%
Fujimura et al[59], 200238% 86%100% 100%67% 92%--
Leeman et al[60], 201758.8%94.1%89.6% 100%66.7%100%86% 98%
False positivesFalse negatives
Stell et al[32], 19968%69%100% 100%0%0%12%4%
Table 4 Patient demographics
Modality
Ref.
Total number of patients
Mean age in years (range)
Gender ratio (M:F)
PETLim et al[11], 20061751.4 (32-74)12:5
Sim et al[33], 20095262 (median) (33-80)43:9
Turlakow et al[34], 20038854 (28-84)50:38
Perlaza et al[36], 20185065.7 ± 12.130:20
Kim et al[37], 20176060.6 (29-80)16:44
Chen et al[38], 20056854.8 (28-81)49:19
Kim et al[39], 201113961.5 ± 11.688:51
MRILin et al[35], 202162 (11 gastric)56 ± 12 (54 ± 13 in gastric)20:42 (6:5 in gastric)
De Vuysere et al[40], 202132(29-85)22:10
Table 5 Tumour characteristics and computed tomography, positron emission tomography or magnetic resonance imaging modality used
ModalityRef.Tumour histologySpecific scanner used
CT
PET/MRI
PETLim et al[11], 2006Moderate differentiation (n = 2)Single-section spiral CT, HiSpeed CT/I or multi-detector CT scanning fourdetector row, LightSpeed PlusGE advance PET scanner or Philips Allegro PET system
Mixed type of moderate and poor differentiation (n = 2)
Signet cell differentiation (n = 4)
Poor differentiation (n = 9)
Sim et al[33], 2009Adenocarcinoma (n = 47)Not mentionedPET/CT system, Philips Gemini, DA best
Signet ring cell (n = 4)
Unknown (n = 1)
Turlakow et al[34], 2003Gastric (n = 48)Not mentionedPET
Ovarian (n = 13)
Adrenocortical (n = 6)
Mesothelioma (n = 21)
Perlaza et al[36], 2018Well-differentiated (n = 4)Somatom sensation 64Hybrid PET/CT biograph mCT 64S
Moderately differentiated (n = 20)
Poorly differentiated (n = 26)
Kim et al[37], 2017Adenocarcinoma (n = 51)16 or 64-detector row CT scanner, LightSpeed 16 or LightSpeed VCTDiscovery ST PET/CT system
Signet ring cell carcinoma (n = 5)
Mucinous carcinoma (n = 4)
Chen et al[38], 2005Adenocarcinoma (n = 13)Somatom Plus-S or Tomoscan 310 or LightSpeed PlusGE Advance
Undifferentiated adenocarcinoma (n = 55)
Kim et al[39], 2011Adenocarcinoma (n = 117)Multi-detector row CT scanners, Somatom Volume ZoomCyclotron RDS-111
Signet ring cell carcinoma (n = 19)
Mucinous adenocarcinoma (n = 1)
Others (n = 2)
MRILin et al[35], 2021Appendiceal (n = 6)Somatom sensation 64, Aquilion 64 or Aquilion ONEMRI
Colon (n = 25)
Ovarian (n = 20)
Gastric (n = 11)
De Vuysere et al[40], 2021Adenocarcinoma (n = 9)Somatom ForceAera 1.5 T scanner
Adenocarcinoma with signet ring cell differentiation (n = 9)
Table 6 Statistical results of computed tomography and positron emission tomography
Ref.Sensitivity
Specificity
Positive predictive value
Negative predictive value
Accuracy
True positive/true negative
False positive/false negative
CT
PET
CT
PET
CT
PET
CT
PET
CT
PET
CT
PET
CT
PET
Lim et al[11], 200696.5%35.3%91.6%98.9%----89.3%89.3%13/876/948/41/11
Sim et al[33], 200986.6%46.6%91.9%94.2%82.3%80%--------
Turlakow et al[34], 200343%57%--100%93%--------
Perlaza et al[36], 201864%68%93%100%----------
Kim et al[37], 201796%50%100%100%100%100%99%89%99%90%----
Chen et al[38], 200580%30%91%98%----89%88%----
Kim et al[39], 201163.6%18.2%97.7%100%----95%93.5%----
Table 7 Statistical results of computed tomography and magnetic resonance imaging
Ref.Sensitivity
Specificity
Positive predictive value
Negative predictive value
Accuracy
Precision
CT
MRI
CT
MRI
CT
MRI
CT
MRI
CT
MRI
CT
MRI
Lin et al[35], 202141.4%69.0%93.9%81.9%----69.4%75.8%85.7%77.4%
De Vuysere et al[40], 202151.4%100%100%100%100%100%31.3%100%38.9%100%--